Clinical Trials
23 trialsAddition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
M.D. Anderson Cancer Center
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
Sichuan University
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Massachusetts General Hospital
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Duke University
UHKT-CAR123-01
Institute of Hematology and Blood Transfusion, Czech Republic
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
M.D. Anderson Cancer Center
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
M.D. Anderson Cancer Center
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
The First Affiliated Hospital with Nanjing Medical University
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL
Zhejiang University
Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)
Xuzhou Medical University
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
M.D. Anderson Cancer Center
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
University of Virginia
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Rutgers, The State University of New Jersey
Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study
Roswell Park Cancer Institute
Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies
Huazhong University of Science and Technology
Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies
Zhejiang University
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
Zhejiang University
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
Shandong University
Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers
Mayo Clinic